Patents by Inventor Indu Isaacs

Indu Isaacs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8796201
    Abstract: Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Grant
    Filed: November 4, 2011
    Date of Patent: August 5, 2014
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lu Shan, Michael Bethune, Chaitan Khosla, Jonathan Gass, Gail G. Pyle, Gary M. Gray, Indu Isaacs, Gregg Strohmeier
  • Patent number: 8618085
    Abstract: Formulations of desoxyepothilones are stable before and after dilution into aqueous media.
    Type: Grant
    Filed: March 15, 2005
    Date of Patent: December 31, 2013
    Assignee: Koasn Biosciences Incorporated
    Inventors: Peter J. Licari, Ziyang Zhong, Indu Isaacs, John G. Augustine
  • Publication number: 20120156253
    Abstract: Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Application
    Filed: November 4, 2011
    Publication date: June 21, 2012
    Inventors: Lu Shan, Michael Bethune, Chaitan Khosla, Jonathan Gass, Gail G. Pyle, Gary M. Gray, Indu Isaacs, Gregg Strohmeier
  • Publication number: 20100137382
    Abstract: Formulations of desoxyepothilones are stable before and after dilution into aqueous media.
    Type: Application
    Filed: March 15, 2005
    Publication date: June 3, 2010
    Inventors: Peter Licari, Ziyang Zhong, Indu Isaacs, John Augustine
  • Publication number: 20080095710
    Abstract: Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Application
    Filed: July 10, 2007
    Publication date: April 24, 2008
    Inventors: Lu Shan, Michael Bethune, Chaitan Khosla, Jonathan Gass, Gail Pyle, Gary Gray, Indu Isaacs, Gregg Strohmeier
  • Publication number: 20070031460
    Abstract: This invention concerns novel methods of enhancing the solubility of a compound. Compositions prepared using such methods are also disclosed. Compositions prepared using the methods have various advantages over conventionally known compositions.
    Type: Application
    Filed: October 11, 2006
    Publication date: February 8, 2007
    Inventors: John Augustine, Kaliappanadar Nellaiappan, Benjamin Isaacs, Indu Isaacs
  • Publication number: 20050277682
    Abstract: Formulations of desoxyepothilones are stable before and after dilution into aqueous media.
    Type: Application
    Filed: March 15, 2005
    Publication date: December 15, 2005
    Inventors: Peter Licari, Ziyang Zhong, Indu Isaacs, John Augustine
  • Publication number: 20050249719
    Abstract: Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Application
    Filed: October 19, 2004
    Publication date: November 10, 2005
    Inventors: Lu Shan, Michael Bethune, Chaitan Khosla, Jonathan Gass, Gail Pyle, Gary Gray, Indu Isaacs, Gregg Strohmeier
  • Publication number: 20050238673
    Abstract: This invention concerns novel methods of enhancing the solubility of a compound. Compositions prepared using such methods are also disclosed. Compositions prepared using the methods have various advantages over conventionally known compositions.
    Type: Application
    Filed: April 27, 2004
    Publication date: October 27, 2005
    Inventors: John Augustine, Kaliappanadar Nellaiappan, Benjamin Isaacs, Indu Isaacs
  • Publication number: 20050142139
    Abstract: This invention provides formulations of the anti-HIV therapeutic, CD4-IgG2, that contain higher concentrations of the therapeutic than were previously prepared, are stable, compatible with lyophilization, and safe to administer. These formulations are suitable for intravenous, subcutaneous and intramuscular delivery, the latter two routes being potentially useful for facilitating self-administration by HIV-infected individuals. This invention is also directed to methods of making the CD4-IgG2 formulations described in the disclosure, and methods of using the formulations to inhibit or prevent infect CD4+ cells from becoming infected with HIV, and to treat subjects having CD4+ cells infected with HIV.
    Type: Application
    Filed: March 19, 2004
    Publication date: June 30, 2005
    Inventors: Norbert Schulke, William Olson, Cherie Parkhurst-Lang, Indu Isaacs